Organovo Holdings, Inc.

NasdaqCM:ONVO Rapport sur les actions

Capitalisation boursière : US$7.1m

Organovo Holdings Croissance future

Future contrôle des critères 2/6

Organovo Holdings's earnings are forecast to decline at 4.3% per annum while its annual revenue is expected to grow at 52% per year. EPS is expected to grow by 23.6% per annum.

Informations clés

-4.3%

Taux de croissance des bénéfices

23.6%

Taux de croissance du BPA

Biotechs croissance des bénéfices27.1%
Taux de croissance des recettes52.0%
Rendement futur des capitaux propresn/a
Couverture par les analystes

Low

Dernière mise à jour06 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

Is Organovo Holdings (NASDAQ:ONVO) In A Good Position To Invest In Growth?

Feb 10
Is Organovo Holdings (NASDAQ:ONVO) In A Good Position To Invest In Growth?

Here's Why We're Not Too Worried About Organovo Holdings' (NASDAQ:ONVO) Cash Burn Situation

Aug 24
Here's Why We're Not Too Worried About Organovo Holdings' (NASDAQ:ONVO) Cash Burn Situation

We're Hopeful That Organovo Holdings (NASDAQ:ONVO) Will Use Its Cash Wisely

May 10
We're Hopeful That Organovo Holdings (NASDAQ:ONVO) Will Use Its Cash Wisely

We're Hopeful That Organovo Holdings (NASDAQ:ONVO) Will Use Its Cash Wisely

Jan 04
We're Hopeful That Organovo Holdings (NASDAQ:ONVO) Will Use Its Cash Wisely

Organovo: New Strategy Targeting Internal Pipeline Development With Customized 3D Human Tissues Offers Upside

May 28

Prévisions de croissance des bénéfices et des revenus

NasdaqCM:ONVO - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
3/31/20260-15N/AN/A1
3/31/20250-15N/AN/A1
6/30/20240-14-12-12N/A
3/31/20240-15-15-15N/A
12/31/20230-19-17-17N/A
9/30/20230-19-16-16N/A
6/30/20230-18-16-15N/A
3/31/20230-17-13-12N/A
12/31/20222-12-10-9N/A
9/30/20222-12-10-10N/A
6/30/20222-12-10-9N/A
3/31/20222-11-9-8N/A
12/31/2021N/A-12-9-9N/A
9/30/2021N/A-11-8-7N/A
6/30/2021N/A-17-13-12N/A
3/31/2021N/A-17-14-13N/A
12/31/2020N/A-17-15-14N/A
9/30/20200-18-14-14N/A
6/30/20202-15-12-12N/A
3/31/20202-19-15-15N/A
12/31/20193-23-17-17N/A
9/30/20193-26-20-20N/A
6/30/20193-26-19-19N/A
3/31/20193-27-20-20N/A
12/31/20184-27-21-21N/A
9/30/20184-28-24-23N/A
6/30/20184-32-25-25N/A
3/31/20185-35N/A-29N/A
12/31/20174-38N/A-30N/A
9/30/20174-40N/A-31N/A
6/30/20174-40N/A-31N/A
3/31/20174-38N/A-29N/A
12/31/20164-36N/A-29N/A
9/30/20163-37N/A-29N/A
6/30/20162-39N/A-32N/A
3/31/20161-39N/A-29N/A
12/31/20151-38N/A-27N/A
9/30/20151-35N/A-25N/A
6/30/20151-32N/A-23N/A
3/31/20151-30N/A-20N/A
12/31/20140-29N/A-19N/A
9/30/20140-27N/A-19N/A
6/30/20140-29N/A-16N/A
3/31/20140-26N/A-16N/A
12/31/20130-35N/A-13N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: ONVO is forecast to remain unprofitable over the next 3 years.

Bénéfices vs marché: ONVO is forecast to remain unprofitable over the next 3 years.

Croissance élevée des bénéfices: ONVO is forecast to remain unprofitable over the next 3 years.

Chiffre d'affaires vs marché: ONVO's revenue (52% per year) is forecast to grow faster than the US market (8.9% per year).

Croissance élevée des revenus: ONVO's revenue (52% per year) is forecast to grow faster than 20% per year.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Insufficient data to determine if ONVO's Return on Equity is forecast to be high in 3 years time


Découvrir les entreprises en croissance